Loading...
Loading...
Among the 8 tracked institutional investors we monitor, KROS (KEROS THERAPEUTICS INC) is held with a combined value of $77.75M across 5,754,673 shares. The largest holder is VANGUARD GROUP INC with a position worth $31.06M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 2 funds increased their holdings. 5 funds reduced their position.
Total Institutional Value
$77.75M
Total Shares Held
5,754,673
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | $31.06M | 0.00% | New |
| 2 | BlackRock, Inc. | $26.63M | 0.00% | +5.3% |
| 3 | STATE STREET CORP | $6.20M | 0.00% | -47.8% |
| 4 | CITADEL ADVISORS LLC | $6.11M | 0.00% | -20.7% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $5.01M | 0.01% | -23.4% |
| 6 | Point72 Asset Management, L.P. | $1.20M | 0.00% | +180.6% |
| 7 | MILLENNIUM MANAGEMENT LLC | $1.18M | 0.00% | -51.5% |
| 8 | FMR LLC | $360.72K | 0.00% | -8.2% |
As of the latest SEC 13F filings, VANGUARD GROUP INC is the largest institutional holder of KROS with a position worth $31.06M, representing 0.00% of their portfolio. In total, 8 institutional investors hold KROS with a combined value of $77.75M.
In the most recent quarter, 1 fund opened a new position in KROS. Additionally, 2 increased their holdings and 5 reduced their positions.
Institutional investors hold $77.75M worth of KROS stock across 8 positions. The largest institutional holder is VANGUARD GROUP INC with $31.06M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For KROS, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their KROS positions.